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A B S T R A C T
In pharmaceutical labs, the major sources of xanthine oxidase enzyme (XO) used for the gout disease experiment
are animals and humans. The aim of this study is to find the lucrative source for the experiment by the evaluation
in vitro and in silico of the inhibitory activity of five essential oils (EOs), against human and bovine milk
xanthine oxidase (HXO and BXO), using molecular docking and an innovative analysis method based on double
enzyme detection (DED), investigated in this work for the first time. The DED method proved its efficacy,
sensitivity, and quickness. The results show that the five EOs give an important inhibition to BXO and HXO with
an IC50 of 3.67 ± 0.17 μg/ml, 3.89 ± 0.11 μg/ml, 3.76 ± 0.18 μg/ml, 2.37 ± 0.23 μg/ml, 3.43 ± 0.56 μg/
ml for HXO, and to BXO with an IC50 of 6.26 ± 0.92 μg/ml, 5.53 ± 0.82 μg/ml, 10.59 ± 1.59 μg/ml,
1.74 ± 1 μg/ml, 5.33 ± 0.13 μg/ml, for respectively, cumin (Cuminum cyminum L.), fennel (Foeniculum vulgare
Mill.), coriander (Coriandrum sativum L.), anise (Pimpinella anisum L.), and caraway (Carum carvi L.) EOs. In silico
study based on molecular docking using autodock vina program was carried out to study the BXO and HXO
inhibition mechanism and involved interactions for the first time. The results show that the five used EOs give an
important and similar inhibition effect against XO with both enzyme sources, therefore we propose the bovine
milk as a new economic enzyme source for lab experiment, which can promote a new, approach in future gout
treatment.
1. Introduction
Aromatherapy based treatment is one of the comparing medications
which use essential oils as the genuine, helpful administrators to treat a
couple of diseases (Ali et al., 2015). Due to their beneficial antioxidant
and anti-inflammatory activities (Zuzarte et al., 2018).
Gout disease continues (Chiang et al., 1994) to spread in the world
without any precise treatment with no side effects have been yet dis-
covered until nowadays, it makes the patient exposed, suffering from
joints and articulation pains and it may paralyze the movement re-
sulting from the excess accumulation of the uric acid in joints and ar-
ticulations (Cotelle, 2001; Dalbeth et al., 2009).
The major cause of gout is the overactivity of the xanthine oxidase
enzyme (XO), found in the liver (Lin et al., 2016). Its normal function is
the oxidation of the hypoxanthine into xanthine and into uric acid
(Battelli et al., 2018), (Fig. 1). The expensive cost of lab experiment and
enzyme extraction puts a serious problem to researchers around the
world, especially the third world. The most used sources of XO enzyme
are human and bovine which are the cases in this paper.
Through this work, we are improving a new economic, lucrative,
and effective enzyme source for the XO inhibition future experiment
and on the other side searching for a relevant treatment with minimum
side effects, using in silico and in vitro studies for the inhibition of
bovine xanthine oxidase (BXO) and human xanthine oxidase (HXO)
milks. The innovative analysis method used for BXO and HXO inhibi-
tion based on the detection of the uric acid by double enzyme technique
(DED) is investigated herein for the first time aiming to improve its
sensitivity, quickness, and effectiveness. Cumin, fennel, coriander,
anise, and caraway are the five essential oils used for the first time as
inhibitors to BXO and HXO. To support our study, molecular docking
was achieved to illustrate the inhibition mechanism and interaction
types with the in vitro model of BXO and HXO, using autodock vina
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with different parameters described here for the first time. The dis-
covery studio visualizer was carried out for results treatment.
2. Materials and methods
2.1. Drugs and chemicals
Human fresh milk was obtained from a volunteer woman 20 days
after delivery (weight: 62 kg, age: 34 years and height: 156 cm); her
diet was mainly medium in proteins, carbohydrates, and healthy fats.
Bovine milk was obtained from a cow firm in the area of Laghouat,
Algeria. Uricase and peroxidase enzymes were purchased from
Spinreact (Esteve de Bas GIRONA – Spain).
Xanthine substrate, dimethyl sulfoxide (DMSO), K2HPO4, ethylene
diamine tetraacetic acid (EDTA) and all other reagents were purchased
from Sigma‐Aldrich (Sigma-Aldrich Chemie GmbH Taufkirchen,
Germany). All other chemicals and solvents used were of analytical
grade.
2.2. Equipment
Gas chromatograph clarus680 (via Perkin elmer, USA), Fiocchetti
Freezer ECT-F −30 °C (Via Panagulis, Luzzara, Italy), refrigerated
centrifuge from Hettich Rotanta 460R (Bäch SZ, Suisse), Clevenger (via
Wisd Wise Therm, GREECE), Microplate reader from URIT UV660
(Guangdong, China).
2.3. Essential oils extraction
Essential oils were isolated from dried and cleaned seed parts of
cumin, fennel, coriander, anise, and caraway. The plants were brought
from a local market in the area of Laghouat city- Algeria; the different
samples of EOs were obtained by hydro-distillation at boiling tem-
perature on a Clevenger device in 3 h. For this purpose, the plants were
dried under ambient conditions (30−38 °C) for seven days and then
250 g of the seeds were separated for the extraction. The samples were
placed in a round flask and then a volume of 1 l of distilled water was
added. Subsequently, the obtained EOs were stored after decantation in
glass vials with sealed caps at 4 °C in the absence of light (pale yel-
lowish essential oil). Volatile oils obtained by hydro-distillation were
examined by GC/MS for chemical composition determination.
2.4. Equipment and GC conditions
2.4.1. Sample preparation
A portion of the sample (2−5 μl) was transferred to a GC vial, di-
luted in hexane (1–2mL) then sealed with a high performance septum.
2.4.2. Analytical conditions
Perkin Elmer Gas Chromatograph Clarus680 coupled to Mass
Spectrometer Clarus SQ 8 0 t. The fused-silica Rtx-5MS (30m×0.25
mmID, 0.25 um df, RESTEK, USA) is directly coupled to the mass
spectrometer. The carrier gas was helium (1ml/min). The program
used was 4min isothermal at 70 °C, then 4 °C/min to 180 °C and 10min
isothermal. The injection port temperature was 250 °C and the detector
temperature was 280 °C. Ionization of the sample components was
performed in the El mode (70 eV). Mass spectrometer scan range was
30–300 amu. The individual constituents were identified by comparing
the mass spectra with spectra stored in the NIST/EPA/NIH mass spec-
tral database. Version 2.0 g, build 19 May 2011.
2.5. Xanthine oxidase enzyme extraction
The extraction process was made according to (Baghiani et al.,
2003) in very strict procedures using a refrigerated centrifuge and a
fresh human and bovine milk (Sharma et al., 2016). The milk (1 L) was
spin-dried in 4500 rpm for 35min at 4 °C and then exposed to several
separations steps and various speeds going from 1800 rpm up to
4500 rpm in 4 °C.
The floating cream was dissolved in a double volume of phosphate
potassium (K2HPO4, 0.2 M) containing 1mm of EDTA. The mixture was
subjected to a soft agitation for two hours, and then spin-dried in
6000 rpm during 20min in 4 °C. Finally, we get enzymes fractions, and
then float was filtered, collected and preserved under −30 °C for the
tests. We decide to work with crude enzyme extracts to accord mimic in
vivo conditions when both enzymes are not free or purified but mixed
with many proteins.
2.6. Principle of double enzyme detection method (DED)
To find an effective and new way to trace the product produced by
HXO and BXO since the uric acid (product target) has no color at the
end of the reaction. We proposed the use of specific reagent to detect
the uric acid in form of quinoneimine colored in purple (Wu et al.,
2015), so we have used the common reagent for the quantitative de-
termination of the uric acid (Spinreact lab) which consists of three
bottles. The first is composed by two enzymes, uricase (120 U/l) and
peroxidase (450 U/l), as well as the hexacyanoferrate (II) of potassium
(42 μmol/L) with amino-antipyrin (0.150mmol/L) named reagent one.
The second is the buffer solution with pH=7.4 at 25 °C (50mmol/L)
with the dicholorohydroxybenzene sulphonate (2 mmol/L) named re-
agent two. The third constitutes the product, which is the uric acid with
a concentration of 100mg/l (595 μmol/L).
Uricase acts on uric acid produced from both HXO and BXO to
produce allantoin, carbon dioxide, and hydrogen peroxide. Hydrogen
peroxide in the presence of peroxidase reacts with a chromogen (amino-
antipyrine and dichloro-hydroxy benzene sulfonate) to yield quinonei-
mine, a purple-colored complex. The absorbance then measured at
510 nm (490–530) is proportional to the amount of uric acid in the
specimen (Fossati et al., 1980) (Fig. 3).
Fig. 1. Reactions schema catalyzed by xanthine oxidase (XO) enzyme.
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2.7. Xanthine oxidase inhibition assay
After addition of the enzyme HXO and BXO extract, the inhibitory
effect of the five essential oils was tested by following the quantity of
the uric acid produced by oxidation of 0.1 g/l of xanthine substrate
dissolved in a buffer (KH2PO4/K2HPO4/KCl, pH 7.4), in the presence of
several concentrations of every inhibitor. The final concentration of
DMSO in the assay was 25 % in total and used to dissolve the EOs. The
absorbance was read at 492 nm in a microplate reader, the inhibitory
activity of these essential oils was compared with the two controls al-
lopurinol and febuxostat that are the specific inhibitors of the XO with
IC50 of 0.937 μg/ml and IC50 of 0.076 μg/ml, respectively (Kapoor and
Saxena, 2014).
The inhibitory activity of EOs was expressed their percentage of
inhibition (I%). So:
= ⎛
⎝
− ⎞
⎠
×I AC AE
AC
% 100
AC: absorbance in the absence of the inhibitor. AE: absorbance in
the presence of the inhibitor.
The IC50 expressed in μg/ml of every essential oil (inhibitory con-
centration of 50 % of the enzymatic activity) was calculated from the
inhibition ratio vs. essential oil concentration curves by regression
analysis. All experiments were done at least ten times. The values of
standard deviations obtained were mostly less than one.
2.8. Statistical analysis of variance (one way ANOVA)
We used in this paper one-way ANOVA, for result analysis. The
value of p < 0.05 was considered as statistically significant.
2.9. Molecular docking of the investigated compounds
To improve the sensitivity, effectiveness, and quickness of the
double enzyme detection technique (DED) with the new inhibitors of
xanthine oxidase. Through this part of this work, we understand the
mechanism of HXO and BXO inhibition improved in vitro by the pro-
posed method (DED). For the best knowledge of these interactions and
inhibition mechanisms, we should choose the target protein from the
protein data bank (PDB) with specific criteria, represented mainly by its
3D active site, which should be interacted with inhibitor. After re-
searching in PDB (protein data bank) (Berman et al., 2000), we found
bovine xanthine oxidase with PDB ID: 3NRZ and human xanthine oxi-
dase with PDB ID: 2CKJ. The first thing done is removing all un-
necessary ligands as all the water molecules, heteroatoms, any co-
crystallized solvent. We selected one major compound in every EOs as
an inhibitor for the docking. The 3D inhibitors' structures were obtained
from the PubChem database (Kim et al., 2019) according to the Lewis
structure. The docking analysis of molecules was carried out using
autodock vinaprogram for molecular docking and virtual screening,
“molecular docking is a computational procedure that attempts to
predict noncovalent binding of macromolecules or, more frequently, of
a macromolecule (receptor) and a small molecule (ligand) efficiently,
starting with unbound structures, structures obtained from molecular
dynamics simulations, or homology modeling. The goal is to predict the
bound conformations and the binding affinity” (Trott and Olson, 2010).
Autodock vina uses two types of docking; blind docking when we at-
tempt to do docking with no information on the active site, autodock
vina finds the site with the most number of accepted conformations,
and specific docking when we fix setting manually by the grid co-
ordinates XYZ.
The docking consists of two main programs. Autodock vinaprogram
for docking of the ligand (inhibitor) to target receptor (protein) in very
specific parameters setting and autodock tools program for the setting
of grid box, ligand-receptor setting, generating the pdbqt format file,
and hydrogens adding. Autodock tools is the complementary program
came with the main program it consists of four main steps; First step
(one), consist of reading our target protein 3NRZ (BXO), and 2CKJ
(HXO) and our target inhibitors in the format of pdb file, the pdb files
are mostly missing hydrogens; Second step (two), consist of adding the
polar hydrogens missing that are required for the pdbqt format, then
generate the protein and inhibitors in format of pdbqt file; Third step
(three), locating the grid box which is a parameter to define the most
adequately center for the docking and will be fixed with the possible
best dimensional point named as X,Y,Z especially for every receptor
(protein); The fourth step (fourth), selecting torsion count is required to
define the rotatable and non-rotatable bond in the ligand (inhibitor). To
run docking, we need to provide a text file named as the target receptor
– ligand in a separate folder containing ligand and protein information
with the set parameters of dimensional point X, Y, Z. Opening the files
directory with the command prompt window will run the docking using
the autodock vina programand the results will be in the same folder of
the file text for the target complex receptor- ligand. The specific
docking type was chosen in this work and the lowest interatomic dis-
tance modes in Å were selected for analyses. Finally, the docking results
generated were directly loaded into the discovery studio visualizer v 4.0
program.
3. Results and discussion
3.1. Essential oils extraction and GC/MS analysis
The average yield of the EOs was ranged from 0.1% to 1.2% all EOs
yields and density were calculated (Table 1). Chromatograms (Fig. 5),
integrations and compounds detected during analyses are summarized
in Table (). Concentrations are based on relative area percentages. As
such, results could be semi/quantitative when the volume of the sample
is considered. The tentatively identified compounds listed are those
which be identified with a high degree of certainty.
We found that the anise essential oil (Table 2, Fig. 5) contained 23
different compounds, including the major compounds anethole or 1-
methoxy-4-propenylbenzene (C10-H12-O). His structure containing an
aromatic hydrocarbon consisting of a benzene ring substituted by a
propenyl group and a methoxy group.
We found in the cumin essential oil (Table 3, Fig. 5) seven different
compounds, including the major compounds propanal, or 2-methyl-3-
phenyl. His structure containing an aromatic hydrocarbon consisting of
a benzene ring substituted by an aldehyde group.
Table 1
xanthine oxidase inhibitory activity with double enzyme detection technique.
Density Yield (%) IC50 d of XO e inhibitory activity (μg/
ml)
HXOb BXO c
Carum carvi L. 0.923 0.98 3.43 ± 0.56 5.33 ± 0.13
Pimpinella anisum L. 0.99 0.39 2.37 ± 0.23 1.74 ± 1
Coriandrum sativum
L.
0.772 0.1 3.76 ± 0.18 10.59 ± 1.59
Foeniculum vulgare
Mill.
0.992 0.37 3.89 ± 0.11 5.53 ± 0.82
Cuminum cyminum
L.
0.869 1.2 3.67 ± 0.17 6.26 ± 0.92
Febuxostata / / 0.076
Allopurinola / / 0.937
Human xanthine
oxidase (HXO)
/ 14.38 /
Bovine xanthine
oxidase (BXO)
/ 5.4 /
a allopurinol and febuxostat were used as a reference compound in this
assay.
b human xanthine oxidase c bovine xanthine oxidase d Half inhibitory con-
centration e xanthine oxidase.
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In the caraway essential oil (Table 4, Fig. 5), we determine four
compounds with two major compounds, the first one is the D-limonene
(C10H16) a terpenic hydrocarbon present in many major oils. The
second major compound is the carvone or 2-methyl-5-(1-methy-
lethenyl)-2-cyclohexen-1-one.
We identified in the coriander essential oil (Table 5, Fig. 5), 18
different compounds with one major compound called B-linalool or 3,7-
diméthyl-1,6-octadien-3-ol. It is a natural substance, terpenoid liquor
that is biosynthesized as D-, L-or dl-linalool by a large group of plants
and herbs.
Finally, we found in the fennel essential oil (Table 6, Fig. 5) 14
different compounds, we selected two major compounds the D-limonene
and estragole (C10H12O) or 1-allyl-4-methoxybenzene, a colorless liquid
with an odor of anise insoluble in water. It is an isomer of anethole,
consists of a benzene ring substituted by a methoxy group and an allyl
group.
The result achieved from these analyses will be used in silico to
understand better the mechanism responsible for the inhibition pro-
cesses between the major compounds cited and the amino acids in the
active site of both HXO and BXO using molecular docking.
3.2. Xanthine oxidase enzyme extraction
The average yield of the enzyme extract obtained from HXO was
about two times bigger than BXO enzyme extract (Table 1); we
concluded that the enzyme richness in the human kind is bigger com-
paring to bovines. The enzyme activities were tested by the proposed
method of (DED) using Uricase POD liquid, after incubating the enzyme
Table 2
Chemical composition of the anise essential oil.
Retention Time Compound Name
7.355 a-pinene
7.856 1,5,5-trimethyl-6-methylene-cyclohexene
8.801 B-pinene
9.156 2,6-octadien-1-ol, 2,7-dimethyl-
9.671 Cyclohexene, 1-methyl-5-(1-methyletheny) (R)
10.462 Benzene, 1-ethyl-2,4-dimethyl-
10.622 Cyclohexene, 1-methyl-5-(1-methylethenyl (R)
12.703 1.6-octadien-3-ol, 3,7-dimethyl-
13.328 1,6-octadien-3-ol, 3,7-dimethyl-
16.759 Estragole
17.184 Estragole
21.406 Anethole
22.286 Cyclohexene, 4-ethenyl-4-methyl-3-(1-methylethenyl)-1-(1-
methylethyl)-, (3R-trans)-
23.807 2-propanone, 1-(4-methoxyphenyl)-
26.023 Hbenzocycloheptene, 2,4a,5.6,7,8,9,9a-octahydro-3,5,5-
trimethyl-9-methylene-, (4aS-cis)-
26.628 4,4-dimethyl-3-(3-methylbut-3-enylidene)-2-methylenebicyclo
(4.1.0heptane
27.013 Longifolene-V4)
27.263 1,3-cyclohexadiene, 5-(1,5-dimethyl-4-hexeny)-2-methyl, IS
(Rs)
29.6841 Cyclohexene-1-acrylic acid, 2,6,6-trimethyl-3-oxo-, methyl
ester
30.279 Isoaromadendrene epoxide
31.52 Spathulenol
32.135 7-epi-cis-sesquisabinene hydrate
33.506 Retinal
Table 3
Chemical composition of the cumin essential oil.
Retention Time Peak Area Compound Name CAS#
8.876 93359424 B-pinene 127-91-3
10.502 460181760 Benzene, 1-methyl-3-(1-methylethyl) 535-77-3
15.194 46616592 Bicyclol2.2.1lheptan-2-one, 1,7.7-trimethyl-,(1S)- 464-48-2
16.934 98980304 1,3-cyclohexadiene-1-methanol, 4-(1-methylethyl) 1413-55-4
18.16 56692320 Phenol, 3(1-methylethy)- 618-45-1
18.69 889608512 Propanal, 2-methyl-3-phenyl
21.561 124283960 Cyclohexanebutanal, 2-methyl-3-oxo-, cis- 92485-93-3
Table 4
Chemical composition of the caraway essential oil.
Retention Time Peak Area Compound Name CAS#
10.707 1455014784 D-limonene 5989-27-5
14.243 8151198,5 Trans-p-mentha-2,8-dienol
14.758 23866332 Limonene oxide, cis- 13837-75-7
18.935 1600324992 Carvone 99-49-0
Table 5
Chemical composition of the coriander essential oil.
Retention Time Peak Area Compound Name CAS#
11.777 39437372 Y-terpinene 99-85-4
12.407 14351695 Cis-linalool oxide 5989-33-3
13.503 5094492672 B-linalool 78-70-6
15.214 211471136 (-)-camphor 464-48-2
16.004 231248352 Endo-borneol 507-70-0
16.369 64656976 Terpinen-4-ol 562-74-3
16.879 464275584 a-terpineol 98-55-5
17.064 97599264 Estragole 140-67-0
17.234 61245724 Decanal 112-31-2
18.675 16845762 Propanal, 2-methyl-3-phenyl- 99-49-0
18.85 40301976 Carvone
19.13 171828832 Geraniol 106-24-1
19.315 42890312 2-decenal, (Z)- 2497-25-8
20.26 88364784 Anethole 104-46-1
20.471 138776752 Thymol 89-83-8
22.601 7604699,5 Phenol, 5-methyl-2-(1-
methylethyl)-, acetate
528-79-0
23.532 156963936 Geranyl acetate 105-87-3
26.253 33108028 2-dodecenal 4826-62-4
Table 6
Chemical composition of the fennel essential oil.
Retention
Time
Peak Area Compound Name CAS#
10.697 89965168 D-limonene 5989-27-5
13.053 72865224 Bicyclo 2.2.1heptan-2-one, 1,3.3-
trimethyl
1195-79-5
13.328 18232080 1,6-octadien-3-ol, 3,7-dimethyl- 78-70-6
15.234 10283799 Bicyclol2.2.1heptan-2-one, 1,7,7-
trimethyl-. (1S)-
464-48-2
16.024 159996304 Endo-bormeol 507-70-0
16.914 394783936 a-terpineol 98-55-5
17.224 4283771648 Estragole 140-67-0
18.7 5673800,5 Benzaldehyde, 4-(1-methylethyl)- 122-03-2
18.865 93496920 (-)-carvone 6485-40-1
20.281 192832368 Anethole 104-46-1
20.486 173414256 Thymol 89-83-8
20.831 12114243 Phenol, 2-methyl-5-(1-methylethyl)- 499-75-2
22.601 10159122 Phenol, 5-methyl-2-(1-methylethyl)
acetate
528-79-0
29.674 36951968 3-methoxycinnamaldehyde 56578-36-0
L. Bou-Salah, et al. Industrial Crops & Products 143 (2020) 111949
4
extract with 0.1 g/l of xanthine substrate diluted in buffer at PH of 7 for
30min, then read at 492 nm after adding Uricase –POD. The results
showed the presence of uric acid colored in purple after reacting with
the Uricase POD. Liquid according to (Fossati et al., 1980), and that
control and confirm the activity of our enzyme extract.
3.3. Xanthine oxidase inhibition assay with the DED method
It was observed that the changes ranged from one to three times
bigger as max between the inhibitions values in the human milk and
bovine milk enzymes (Table 1). The EOs in the HXO achieved less IC50.
We conclude that the EOs had an affinity toward the HXO enzyme
compared with the bovine milk enzyme (BXO), this explains the nature
of both source origins and its effect on the genetic structure compared
with humans. Although this genetic structure changing did not affect
very significantly on the inhibition between the two sources.
Experiments on XO inhibition were conducted from 1999 to
nowadays by different groups of researchers using two methods, spec-
trophotometric method measuring the released amount of uric acid at
292 nm (Kong et al., 2000) and HPLC method measuring the same
product (Mohamed Isa et al., 2018). The first method is less sensitive
when we use inhibitors with aromatic rings because they absorb at the
same wavelength then interfering with the results. The second method
is effective and precise, but it takes a long time. Hence, this paper
proposes a new approach to measure uric acid based on the use of two
enzymes instead of one enzyme (in the routine method), which in-
creases the accuracy of the detection of the product by the reagent
which is the enzyme 2 which is originally the specific reagent of the
product in our case (uric acid). According to the results obtained by
statistical analysis of variance indicate that all groups tested have a F
stat bigger than the Fcrit and all of them have P-value smaller than 0.05
briefly, our proposed method is good. It has many interesting, attractive
Fig. 2. A: the 3D structure of the human xanthine oxidase HXO 2CKJ (Chain A) colored by structure: B: the 3D structure of the bovine xanthine oxidase 3NRZ (Chain
C) colored by structure C: zooming in the active site of both enzymes complexed with ligand: flavin-adenine dinucleotide (FAD).
Fig. 3. Schema of reactions reported from literature (Avis et al., 1956).
(a) Incubation of uric acid with urate oxidase [only the final products are reported (hydroxyisouric acid; the product of the enzyme reaction is unstable and no
enzymatically converted into allantoin, CO2, and H2O2)], (b) DCHBS oxidation catalyzed by HRP in the presence of hydrogen peroxide, and (c) phenoxyl radical
reaction with 4AAP, producing a purple quinoneimine dye.
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and valuable applications in drug design with practical quickness. The
obtained results show that all the essential oils inhibit the activity of the
HXO and BXO very significantly, compared with the controls
(allopurinol and febuxostat) (Table 1). Used as an effective medicine for
this disease, which causes serious side effects. We could not discuss our
results with other researches in literature because there is no research
Fig. 4. The docking pose with the inhibitors on the active site of HXO and BXO for A: anethole, B: carvone, C: D-limonene, D: linalool, and E: propanal. Inhibitors:
presented in sticks and colored by default atom color, amino acids: presented in lines and colored by default atom color.
L. Bou-Salah, et al. Industrial Crops & Products 143 (2020) 111949
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Fig. 5. Gas chromatography (GC) profiles of EOs from five species: (AG) anise essential oil; (CC1) cumin essential oil; (CC2) caraway essential oil; (CS) coriander
essential oil and (FV2) fennel essential oil.
L. Bou-Salah, et al. Industrial Crops & Products 143 (2020) 111949
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similar to ours, only the nearest one was done by a group of Taiwan
researchers when attempting to inhibit the XO by the essential oil of C.
osmophloeum leaves and presented the strongest XO inhibition activity
with an IC50 of 16.3 mg/ml (Wang et al., 2008).
3.4. Molecular modeling and docking of the investigated compounds
The analyses using the discovery studio visualizer program revealed
that the human xanthine oxidase (HXO) with PDB ID: 2CKJ (Fig. 2) is
an enzyme with four chains of 5314 amino acids named A: (ALA3-
TRP1329), B: (THR2- ARG1332), C: (ALA3- ARG1332), and D: (ALA3-
ARG1332). It is a big size enzyme with a molecular weight of 592 kDa.
The active site is a cavity divided into two sections. One section imparts
specificity to the ligand (substrate or inhibitor), and the second is
preserved to the cofactors, in this case, is complex with phosphate ions
(PO43-), Flavin-adenine dinucleotide (FAD), glycerol (GOL), acetic acid
(ACY), and iron2+ sulfide (FES). The docking site was centered at the
following amino acids of the chain A: (GLN112, CYS150, GLN768,
GLY797, GLY798, GLY1262, PHE799, PHE915, GLY800, ARG913,
MET1039, GLY1040, GLN1041, ALA911, SER1081, GLN1195, and
GLU1262). The bovine xanthine oxidase (BXO) with PDB ID: 3NRZ
(Fig. 2) is an enzyme with three chains of 1222 amino acids named A:
(THR2- LYS165), B: (PRO224- GLY528), and C: (ASP571- LYS1326).). It
is an enzyme with a molecular weight of 274 kDa. The active site of
3NRZ is a small cavity, and from a structural point of view, it is divided
into two sections. One section impart specificity to the ligand (substrate
or inhibitor), and the second is preserved to the cofactors, in this case is
complex with hypoxanthine (HPA), flavin adenine dinucleotide (FAD),
iron2+ sulfide (FES), dioxothiomolybdenum (MOS), phosphonic acid-
mono-(2-amino-5,6-dimercapto-4-oxo-3, 7, 8a, 9, 10,10a-hexahydro-
4h-8-oxa-1,3,9,10-tetraaza-anthracen-7- ylmethyl) ester (MTE). The
docking site was centered at the following amino acids of the chain C:
(GLU802, MET1038, LEU873, SER876, ARG880, ALA910, GLY913,
PHE914, PHE1005, SER1008, PHE1009, THR1083, THR1010,
VAL1011, LEU1014, PRO1076, ALA1078, ALA1079, SER1082, and
GLU1261). The docking parameters were fixed on the grid box with
(x= 37.338, y= 19.791, z= 17.854) and (x= 79.017, y= 77.284,
z= 141.85) for respectively 3NRZ (BXO) and 2CKJ (HXO), hydrogens
were added to both proteins. The docking results showed multiples
solutions with up to 50 confirmations saved per molecule. The lowest
interatomic distance modes in Å between ligand-receptor were used
(Fig. 4). In addition, we defined the amino acids in the binding site of
both HXO and BXO responsible for the interaction with the inhibitors,
CYS150, MET1039, ARG913 GLN768, and PHE799 are responsible for
the interaction in the active site of HXO, While THR1010, PHE1009,
PHE914, ALA1079, LEU873, SER1082 are responsible for the interac-
tion in the active site of BXO. The results show that the anethole has a
minimum distance of 3.24 Å with THR1010 in the BXO, and 3.67 Å with
CYS150 in the HXO. For carvone, we scored 3.32 Å with ALA1079 in
the BXO, and 4.21 Å with CYS150 in the HXO. With D-limonene, we
saved 3.69 Å with PHE914 in the BXO and 4.21 with CYS150 in the
HXO. While in the linalool, 3.12 Å with THR1083 in the BXO and
2.96 Å with GLN768 in the HXO. In addition, we saved in propanal
3.32 Å with THR1010 in the BXO and 3.25 Å with PHE799 in the HXO.
The all-interatomic distances saved was ranged from 2.96 Å to 4.21 Å
with a difference of only 1.25 Å, in this case we concluded that all the
inhibitors tested in both HXO and BXO are the same in term of in-
teratomic distance. The types of involved interaction were determined,
where we observed in this context that the bonds type between the CYS,
GLN, and PHE in the HXO and the different inhibitors reported in this
work were hydrogens bonds type, while THR, ALA, PHE, and SER active
site amino acids in the BXO were also hydrogens bonds type. For the
first time in this study, the docking of HXO and BXO with these para-
meters is achieved and no further studies were found in this context.
3.5. In silico and in vitro assays
In this study, we have shown the results obtained by inhibition of
the XO responsible for gout disease (Table 1) by the power of five EOs.
The enzyme has been extracted from two different sources: human milk
and bovine milk, which are two of the most frequent, used sources in
lab experiments, to compare the genetic effect on the enzymes active
site structure and their affinity toward this EOs and to understand and
clarify the differences between them. We concluded that the differences
between the two xanthine oxidase enzyme from human and bovine are
not significant in term of inhibition affinity, interatomic distance and
bond type. After the results achieved in this research, it is possible to
carry out future laboratory experiments to develop a drug for this dis-
ease using available XO enzyme from bovine milk instead of human
milk, which is very difficult and charged. We also use in this work an
innovative method to detect the colorless product (uric acid) in the
original enzyme method, which is characterized by its effectiveness,
ease, and economical compared with the methods used in the other
research.
4. Conclusion
Through this work, we tested the most known essential oils in the
area of Laghouat city, Algeria for their activity to inhibit the xanthine
oxidase enzyme from two different sources, which is a therapeutic
target for the gout disease. Based on the achieved results, we suggest
the use of the XO enzyme extracted from bovine milk as an alternative
to future laboratory experiments for ease of access, adequate, and lower
costs. The evidence from this study suggests that the method of double
enzyme detection (DED) is accurate, precise, quick, sensible, re-
producible, and efficacy method according to ANOVA analysis.
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